Partner Investment Management, L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 70 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Partner Investment Management, L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2019$782,000
-9.0%
9,766
-38.7%
0.90%
-15.8%
Q4 2018$859,000
-28.7%
15,932
+3.2%
1.07%
+16.3%
Q3 2018$1,205,000
+94.0%
15,437
+57.7%
0.92%
+84.2%
Q2 2018$621,000
-35.2%
9,789
-6.3%
0.50%
-51.6%
Q1 2018$958,000
+26.7%
10,446
+4.3%
1.04%
+18.8%
Q4 2017$756,000
-49.0%
10,020
-52.9%
0.87%
-38.0%
Q3 2017$1,481,000
+56.9%
21,252
+14.1%
1.40%
+10.8%
Q2 2017$944,000
+49.8%
18,622
+18.2%
1.27%
+65.3%
Q1 2017$630,000
+111.4%
15,748
+48.1%
0.77%
+94.2%
Q4 2016$298,000
+8.4%
10,635
+14.8%
0.40%
-3.2%
Q3 2016$275,000
-32.3%
9,262
-53.8%
0.41%
-38.6%
Q2 2016$406,000
+19.8%
20,049
+6.7%
0.66%
+20.3%
Q1 2016$339,000
-28.6%
18,788
+4.1%
0.55%
-29.1%
Q4 2015$475,000
+118.9%
18,052
+77.8%
0.78%
+137.5%
Q3 2015$217,000
+11.3%
10,154
+38.1%
0.33%
+19.7%
Q2 2015$195,0007,3500.27%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders